Annual Current Ratio
1.64
-0.90-35.43%
December 31, 2023
Summary
- As of February 7, 2025, XERS annual current ratio is 1.64, with the most recent change of -0.90 (-35.43%) on December 31, 2023.
- During the last 3 years, XERS annual current ratio has fallen by -3.76 (-69.63%).
- XERS annual current ratio is now -87.51% below its all-time high of 13.13, reached on December 31, 2016.
Performance
XERS Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
1.79
-0.47-20.80%
September 30, 2024
Summary
- As of February 7, 2025, XERS quarterly current ratio is 1.79, with the most recent change of -0.47 (-20.80%) on September 30, 2024.
- Over the past year, XERS quarterly current ratio has dropped by -0.03 (-1.65%).
- XERS quarterly current ratio is now -89.17% below its all-time high of 16.53, reached on September 30, 2018.
Performance
XERS Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
XERS Current Ratio Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -35.4% | -1.6% |
3 y3 years | -69.6% | -1.6% |
5 y5 years | -85.8% | -1.6% |
XERS Current Ratio Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -35.4% | at low | -33.0% | +9.2% |
5 y | 5-year | -69.6% | at low | -73.9% | +9.2% |
alltime | all time | -87.5% | at low | -89.2% | +9.2% |
Xeris Biopharma Holdings Current Ratio History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | 1.79(-20.8%) |
Jun 2024 | - | 2.26(-4.6%) |
Mar 2024 | - | 2.37(+44.5%) |
Dec 2023 | 1.64(-35.4%) | 1.64(-9.9%) |
Sep 2023 | - | 1.82(-6.7%) |
Jun 2023 | - | 1.95(-3.9%) |
Mar 2023 | - | 2.03(-20.1%) |
Dec 2022 | 2.54(+41.1%) | 2.54(+17.1%) |
Sep 2022 | - | 2.17(-13.2%) |
Jun 2022 | - | 2.50(-6.4%) |
Mar 2022 | - | 2.67(+48.3%) |
Dec 2021 | 1.80 | 1.80(-46.1%) |
Sep 2021 | - | 3.34(-18.1%) |
Jun 2021 | - | 4.08(-30.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | 5.86(+8.5%) |
Dec 2020 | 5.40(+68.8%) | 5.40(-10.6%) |
Sep 2020 | - | 6.04(-12.0%) |
Jun 2020 | - | 6.86(+42.3%) |
Mar 2020 | - | 4.82(+50.6%) |
Dec 2019 | 3.20(-72.4%) | 3.20(-46.3%) |
Sep 2019 | - | 5.96(-0.7%) |
Jun 2019 | - | 6.00(-47.6%) |
Mar 2019 | - | 11.45(-1.2%) |
Dec 2018 | 11.59(+27.9%) | 11.59(-29.9%) |
Sep 2018 | - | 16.53(+10.9%) |
Jun 2018 | - | 14.91(+129.0%) |
Mar 2018 | - | 6.51(-28.1%) |
Dec 2017 | 9.06(-31.0%) | 9.06 |
Dec 2016 | 13.13 | - |
FAQ
- What is Xeris Biopharma Holdings annual current ratio?
- What is the all time high annual current ratio for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual current ratio year-on-year change?
- What is Xeris Biopharma Holdings quarterly current ratio?
- What is the all time high quarterly current ratio for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly current ratio year-on-year change?
What is Xeris Biopharma Holdings annual current ratio?
The current annual current ratio of XERS is 1.64
What is the all time high annual current ratio for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual current ratio is 13.13
What is Xeris Biopharma Holdings annual current ratio year-on-year change?
Over the past year, XERS annual current ratio has changed by -0.90 (-35.43%)
What is Xeris Biopharma Holdings quarterly current ratio?
The current quarterly current ratio of XERS is 1.79
What is the all time high quarterly current ratio for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly current ratio is 16.53
What is Xeris Biopharma Holdings quarterly current ratio year-on-year change?
Over the past year, XERS quarterly current ratio has changed by -0.03 (-1.65%)